SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

VINCENZI, Fabrizio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 17.371
AS - Asia 9.084
EU - Europa 5.331
SA - Sud America 1.574
Continente sconosciuto - Info sul continente non disponibili 435
AF - Africa 222
OC - Oceania 12
AN - Antartide 1
Totale 34.030
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.879
SG - Singapore 3.343
CN - Cina 2.205
IT - Italia 1.403
BR - Brasile 1.223
VN - Vietnam 1.097
DE - Germania 818
HK - Hong Kong 710
UA - Ucraina 547
GB - Regno Unito 480
PL - Polonia 437
TR - Turchia 437
FI - Finlandia 380
FR - Francia 315
CA - Canada 284
BD - Bangladesh 283
SE - Svezia 278
JP - Giappone 231
RU - Federazione Russa 206
IN - India 202
ID - Indonesia 152
AR - Argentina 121
MX - Messico 118
NL - Olanda 105
ZA - Sudafrica 88
IQ - Iraq 62
ES - Italia 61
CO - Colombia 55
BE - Belgio 50
EC - Ecuador 50
AT - Austria 48
PK - Pakistan 45
LT - Lituania 41
UZ - Uzbekistan 41
MY - Malesia 38
VE - Venezuela 38
CZ - Repubblica Ceca 32
SA - Arabia Saudita 32
CL - Cile 28
MA - Marocco 27
AE - Emirati Arabi Uniti 26
KE - Kenya 26
JM - Giamaica 24
PH - Filippine 24
TN - Tunisia 24
CH - Svizzera 23
PY - Paraguay 22
CR - Costa Rica 17
KR - Corea 17
EG - Egitto 16
JO - Giordania 16
IE - Irlanda 15
IL - Israele 15
NP - Nepal 14
BO - Bolivia 13
HN - Honduras 13
AU - Australia 12
DZ - Algeria 12
PE - Perù 11
PT - Portogallo 11
UY - Uruguay 11
ET - Etiopia 10
TW - Taiwan 10
BG - Bulgaria 9
EU - Europa 8
IR - Iran 8
KZ - Kazakistan 8
PS - Palestinian Territory 8
TH - Thailandia 8
HU - Ungheria 7
KG - Kirghizistan 7
LV - Lettonia 7
RS - Serbia 7
AL - Albania 6
BA - Bosnia-Erzegovina 6
BH - Bahrain 6
RO - Romania 6
DO - Repubblica Dominicana 5
GR - Grecia 5
MD - Moldavia 5
PA - Panama 5
SY - Repubblica araba siriana 5
AZ - Azerbaigian 4
BY - Bielorussia 4
CG - Congo 4
CI - Costa d'Avorio 4
GT - Guatemala 4
HR - Croazia 4
LB - Libano 4
NI - Nicaragua 4
NO - Norvegia 4
OM - Oman 4
TT - Trinidad e Tobago 4
AM - Armenia 3
CY - Cipro 3
GE - Georgia 3
KH - Cambogia 3
KW - Kuwait 3
MK - Macedonia 3
PR - Porto Rico 3
Totale 33.563
Salva come PNG Salva come JPEG
Città #
Singapore 2.107
Ashburn 2.104
San Jose 1.267
Fairfield 1.189
Woodbridge 1.156
Chandler 796
Beijing 784
Houston 743
Santa Clara 738
Ann Arbor 709
Hong Kong 691
Jacksonville 621
Council Bluffs 545
Seattle 506
Wilmington 473
Cambridge 421
Warsaw 419
Los Angeles 386
Ferrara 377
Ho Chi Minh City 345
New York 314
Dallas 300
Hanoi 267
Munich 248
Izmir 236
Tokyo 216
Nanjing 169
Helsinki 167
Princeton 163
Lauterbourg 162
Milan 159
Shanghai 137
São Paulo 125
Boardman 119
Jakarta 117
Orem 111
San Diego 110
Buffalo 102
Toronto 95
Turku 90
London 83
Chicago 82
Montreal 71
The Dalles 71
Bologna 70
Chennai 69
Frankfurt am Main 66
Denver 65
Mexico City 65
Tianjin 62
Phoenix 59
Da Nang 58
Bremen 57
Brooklyn 56
Nanchang 53
San Francisco 52
Johannesburg 51
Shenyang 49
Atlanta 47
Brussels 47
Dearborn 47
Rome 45
Stockholm 45
Boston 43
Hefei 43
Manchester 43
Haiphong 41
Moscow 37
Hebei 36
Nuremberg 36
Tashkent 36
Columbus 35
Jiaxing 35
Falls Church 34
Falkenstein 33
Poplar 33
Amsterdam 32
Changsha 31
Rio de Janeiro 31
Belo Horizonte 28
Washington 28
Ankara 25
Auburn Hills 24
Norwalk 24
Zhengzhou 24
Brno 23
Curitiba 23
Dong Ket 22
Baghdad 21
Biên Hòa 21
Des Moines 21
Guangzhou 21
Mountain View 21
Porto Alegre 21
Charlotte 20
Florence 19
Kuala Lumpur 19
Zurich 19
Augusta 18
Brasília 18
Totale 22.193
Salva come PNG Salva come JPEG
Nome #
Effect of the novel synthetic cannabinoids AKB48 and 5F-AKB48 on “tetrad”, sensorimotor, neurological and neurochemical responses in mice. In vitro and in vivo pharmacological studies 428
Pharmacology of Adenosine Receptors: The State of the Art 423
Synthesis and Structure Activity Relationship Investigation of Triazolo[1,5-a]pyrimidines as CB2 Cannabinoid Receptor Inverse Agonists 317
Psychostimulant effect of the synthetic cannabinoid JWH-018 and AKB48. Behavioural, neurochemical and Dopamine transporter scan imaging studies in mice 310
Positive allosteric modulation of A1 adenosine receptors as a novel and promising therapeutic strategy for anxiety 304
Inhibition of A2A Adenosine Receptor Signaling in Cancer Cells Proliferation by the Novel Antagonist TP455 300
The A3 adenosine receptor: history and perspectives 294
A(2B) adenosine receptors stimulate IL-6 production in primary murine microglia through p38 MAPK kinase pathway 294
Effect of JWH-250, JWH-073 and their interaction on “tetrad”, sensorimotor, neurological and neurochemical responses in mice 291
Design, synthesis, and biological evaluation of novel 2-((2-(4-(substituted)phenylpiperazin-1-yl)ethyl)amino)-5'-N-ethylcarboxamidoadenosines as potent and selective agonists of the A2A adenosine receptor 286
ALTERED EXPRESSION AND FUNCTIONALITY OF A2A ADENOSINE RECEPTORS IN HUNTINGTON’S DISEASE AND OTHER POLYGLUTAMINE DISORDERS 285
Novel halogenated derivates of JWH-018: Behavioral and binding studies in mice 284
2-Arylpyrazolo[4,3-d]pyrimidin-7-amino derivatives as new potent and selective human A3 adenosine receptor antagonists. Molecular modeling studies and pharmacological evaluation 284
Age-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S LRRK2 mice 276
Pulsed Electromagnetic Field Exposure Reduces Hypoxia and Inflammation Damage in Neuron-Like and Microglial Cells 273
Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease 272
Characterization of adenosine receptors in bovine chondrocytes and fibroblast-like synoviocytes exposed to low frequency low energy pulsed electromagnetic fields 269
Pulsed Electromagnetic Fields: A Novel Attractive Therapeutic Opportunity for Neuroprotection After Acute Cerebral Ischemia 269
A2A and A3 adenosine receptor expression in rheumatoid arthritis: upregulation, inverse correlation with disease activity score and suppression of inflammatory cytokine and metalloproteinase release 268
Repeated dosing with NCX1404, a nitric oxide-donating pregabalin, re-establishes normal nociceptive responses in mice with streptozotocin-induced painful diabetic neuropathy 266
7-Oxo-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxamides as Selective CB2 Cannabinoid Receptor Ligands: Structural Investigations around a Novel Class of Full Agonists 261
Adenosine analogs and electromagnetic fields inhibit prostaglandin E2 release in bovine synovial fibroblasts 261
The role of 5-arylalkylamino- and 5-piperazino- moieties on the 7-aminopyrazolo[4,3-d]pyrimidine core in affecting adenosine A1 and A2A receptor affinity and selectivity profiles 257
A(2A) adenosine receptors are differentially modulated by pharmacological treatments in rheumatoid arthritis patients and their stimulation ameliorates adjuvant-induced arthritis in rats 253
Role and function of A2A and A3 adenosine receptors in patients with ankylosing spondylitis, psoriatic arthritis and rheumatoid arthritis 247
A(2A) adenosine receptors are up-regulated in lymphocytes from amyotrophic lateral sclerosis patients 247
Expression and functional role of adenosine receptors in regulating inflammatory responses in human synoviocytes. 246
Pharmaco-toxicological effects of the novel third-generation fluorinate synthetic cannabinoids, 5F-ADBINACA, AB-FUBINACA, and STS-135 in mice. In vitro and in vivo studies 245
Multiple sclerosis lymphocytes upregulate A(2A) adenosine receptors that are antiinflammatory when stimulated 241
One-pot reaction to obtain N,N'-disubstituted guanidines of pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine scaffold as human A3 adenosine receptor antagonists 236
A3 Receptors are Overexpressed in Pleura from Mesothelioma Patients and Reduce Cell Growth via Akt/NF-kB Pathway. 232
Structural refinement of pyrazolo[4,3-d]pyrimidine derivatives to obtain highly potent and selective antagonists for the human A3 adenosine receptor 230
Alteration of adenosine receptore in patients with chronic obstructive pulmonary disease 228
Design, Synthesis, and Pharmacological Characterization of 2-(2-Furanyl)thiazolo[5,4-d]pyrimidine-5,7-diamine Derivatives: New Highly Potent A2A Adenosine Receptor Inverse Agonists with Antinociceptive Activity 227
ALTERATION OF ADENOSINE RECEPTORS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE 226
A3 adenosine receptors are overexpressed in pleura from patients with mesothelioma and reduce malignant mesothelioma cell growth 226
M3 muscarinic receptors in peripheral lung parenchima of patients with chronic obstructive pulmonary disease. 223
The Anti-Tumor Effect of A(3) Adenosine Receptors Is Potentiated by Pulsed Electromagnetic Fields in Cultured Neural Cancer Cells 223
A2A adenosine receptor upregulation correlates with disease activity in patients with systemic lupus erythematosus 222
Targeting A3 and A2A adenosine receptors in the fight against cancer 222
P2X1 and P2X3 Purinergic Receptors Differentially Modulate the Inflammatory Response in Human Osteoarthritic Synovial Fibroblasts 220
Binding and signaling studies disclose a potential allosteric site for cannabidiol in cannabinoid CB2 receptors 220
Adenosine Receptors as a Biological Pathway for the Anti-Inflammatory and Beneficial Effects of Low Frequency Low Energy Pulsed Electromagnetic Fields 220
Pathological overproduction: the bad side of adenosine 219
[3H]MRE2029F20 a new selective antagonist radioligand for the human A2B adenosine receptors. 218
F638 a nitric oxide (NO)-donating gabapentin, NCX 1236, reverses the development of mechanical allodynia in streptozotocin-treated diabetic mice. 216
Synthesis and Biological Evaluation of Novel Allosteric Enhancers of the A1 Adenosine Receptor Based on 2-Amino-3-(4’-Chlorobenzoyl)-4-Substituted-5-Arylethynyl Thiophene 213
Electromagnetic fields (EMFs) and adenosine receptors modulate prostaglandin E(2) and cytokine release in human osteoarthritic synovial fibroblasts 210
Deficiency of polycystic kidney disease-1 gene (PKD1) expression increases A(3) adenosine receptors in human renal cells: Implications for cAMP-dependent signalling and proliferation of PKD1-mutated cystic cells. 207
Binding thermodynamic characterization of human P2X1 and P2X3 purinergic receptors 206
Expression and functional role of adenosine receptors in regulating inflammatory responses in human synoviocytes 206
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 206
7-Amino-2-phenylpyrazolo[4,3-d]pyrimidine derivatives: Structural investigations at the 5-position to target human A(1) and A(2A) adenosine receptors. Molecular modeling and pharmacological studies 205
Pharmacological characterization of adenosine receptors in bovine chondrocytes. 202
Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[N- (substituted) piperazin-1-yl]thiophenes as potent allosteric enhancers of the A1 adenosine receptor 201
Biochemical and pharmacological role of A1adenosine receptors and their modulation as novel therapeutic strategy 201
Cannabigerol action at cannabinoid CB1 and CB2 receptors and at CB1-CB2 heteroreceptor complexes 201
Pulsed electromagnetic field and relief of hypoxia-induced neuronal cell death: The signaling pathway 201
Thermodynamic analysis in drug-receptor binding: the A3 adenosine receptor 200
RAW 264.7 co-cultured with ultra-high molecular weight polyethylene particles spontaneously differentiate into osteoclasts: an in vitro model of periprosthetic osteolysis 198
Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[(4- arylpiperazin-1-yl)methyl]-5-substituted-thiophenes. Effect of the 5-modification on allosteric enhancer activity at the A1 adenosine receptor 198
NCX 1236, a novel gabapentin endowed of nitric oxide-releasing properties, reverses the development of mechanical allodynia in streptozotocin-treated diabetic mice 191
Effect of pulsed electromagnetic field exposure on adenosine receptors in rat brain 190
A2A Adenosine Receptor as a Potential Biomarker and a Possible Therapeutic Target in Alzheimer's Disease 190
Effect of low frequency electromagnetic fields on A2A and A3 adenosine receptors in human neutrophils 188
Development of novel pyridazinone-based adenosine receptor ligands 188
Effects of pulsed electromagnetic field exposure and adenosine analogues on prostaglandin release in bovine synovial fibroblasts. 186
Deficiency of polycystic kidney disease-1 gene (PKD1) expression increases A3 adenosine receptors in human renal cells 186
A2A Adenosine Receptor: A Possible Therapeutic Target for Alzheimer's Disease by Regulating NLRP3 Inflammasome Activity? 185
Adenosine receptors in bovine chondrocytes and fibroblast-like synoviocytes 184
A3 Adenosine and P2X7 Purinergic Receptors as New Targets for an Innovative Pharmacological Therapy of Malignant Pleural Mesothelioma 182
Signaling pathways involved in anti-inflammatory effects of Pulsed Electromagnetic Field in microglial cells 180
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 179
A2A adenosine receptor overexpression and functionality, as well as TNF-alpha levels, correlate with motor symptoms in Parkinson's disease. 179
A2A Adenosine Receptor Antagonists in Neurodegenerative Diseases 177
Effects of pulsed electromagnetic field exposure on adenosine receptors in human fibroblast-like synoviocytes. 176
Functional tissue engineering in articular cartilage repair: is there a role for electromagnetic biophysical stimulation? 176
Electromagnetic fields (EMFs) and adenosine receptors modulate prostaglandin E2 and cytokine production in human osteoarthritic synovial fibroblasts 175
2-Phenylpyrazolo[4,3-d]pyrimidin-7-one as a New Scaffold To Obtain Potent and Selective Human A(3) Adenosine Receptor Antagonists: New Insights into the Receptor-Antagonist Recognition (dagger). 175
A2A adenosine receptors and chronic caffeine intake in human neutrophils 173
The role of adenosine receptors in rheumatoid arthritis. 172
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 172
Amino-3, 5-dicyanopyridines targeting the adenosine receptors ranging from pan ligands to combined A1/A2B partial agonists 172
L-DOPA promotes striatal dopamine release through D1 receptors and reversal of dopamine transporter 171
Synthesis, structure-affinity relationships, and molecular modeling studies of novel pyrazolo[3,4-c]quinoline derivatives as adenosine receptor antagonists 170
Effects of pulsed electromagnetic fields and platelet rich plasma in preventing osteoclastogenesis in an in vitro model of osteolysis 169
Adenosine and inflammation: Here, there and everywhere 168
Effect of chronic caffeine intake on A2A adenosine receptors in human neutrophils. 168
Development of Epigenetic Modifiers with Therapeutic Potential in FMS-Related Tyrosine Kinase 3/Internal Tandem Duplication (FLT3/ITD) Acute Myeloid Leukemia and Other Blood Malignancies 167
Scouting human A3 adenosine receptor antagonist binding mode using a molecular simplification approach: From triazoloquinoxaline to a pyrimidine skeleton as a key study 167
A Novel Conjugated Agent between Dopamine and an A(2A) Adenosine Receptor Antagonist as a Potential Anti-Parkinson Multitarget Approach. 167
In Vivo Bio-Activation of JWH-175 to JWH-018: Pharmacodynamic and Pharmacokinetic Studies in Mice 166
Caffeine for Prevention of Alzheimer's Disease: Is the A2A Adenosine Receptor Its Target? 166
Effect of chronic caffeine intake on A2A adenosine receptors in human neutrophils. 165
Caffeine intake induces an alteration of human neutrophils A2A adenosine receptors. 165
Development of potent and selective FAAH inhibitors with improved drug-like properties as potential tools to treat neuroinflammatory conditions 164
Structure-activity relationships of 2-amino-3-aroyl-4-[(4-arylpiperazin-1- yl)methyl]thiophenes. Part 2: Probing the influence of diverse substituents at the phenyl of the arylpiperazine moiety on allosteric enhancer activity at the A 1 adenosine receptor 164
Antinociceptive effects of the selective CB2 agonist MT178 in inflammatory and chronic rodent pain models. 163
Upregulation of Cortical A2Aadenosine receptors is reflected in platelets of patients with Alzheimer's Disease 163
Imidazo[1,2-a]pyrazin-8-amine core for the design of new adenosine receptor antagonists: Structural exploration to target the A3 and A2A subtypes 161
Totale 21.914
Salva come PNG Salva come JPEG
Categoria #
all - tutte 149.358
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.587
Totale 151.945
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.296 0 0 119 34 50 82 101 97 63 128 237 385
2022/20231.779 176 190 47 259 260 220 122 143 192 18 85 67
2023/20241.078 88 111 51 33 106 137 66 116 19 41 38 272
2024/20255.044 109 151 374 288 469 510 241 284 803 515 695 605
2025/202613.732 1.329 544 1.110 1.570 2.017 926 1.558 773 1.273 1.535 690 407
2026/20271.709 472 911 326 0 0 0 0 0 0 0 0 0
Totale 34.030